Sign in

NCT05622396Completed

Feasibility of an Adapted Mindfulness Program to Parkinson's Disease

A Pilot Feasibility Study of a Co-constructed Program (Patients - Experts) of Mindfulness Meditation Adapted to Patients With Parkinson's Disease.

Source: ClinicalTrials.gov · Last updated 18 Jun 2026

Brief summary (registry, in English)

The objective of this study is to determine the feasibility (primary objective) and the effects (secondary objectives) of an Mindfulness Based Stress Reduction (MBSR) program adapted specifically for patients with Parkinson's disease.

Status (registry)
Completed
Study type
Interventional
Enrollment
20 (actual)
First submitted
27 Oct 2022
Start date
6 Feb 2023
Primary completion date
6 Dec 2023
Lead sponsor
University Hospital, Bordeaux
NCT number
NCT05622396

What you commit to

  • Study type: Interventional
  • Participants enrolled: 20
  • From 6 Feb 2023 to the primary completion date, 6 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patient with severe motor fluctuations (i.e. scoring 4 to at least one of the following items of part IV of the Movement Disorder Society Unified Parkinson Disease Rating Scale: 4.1 and 4.2 for dyskinesias; 4.3, 4.4 and 4.5 for motor fluctuations),
  • Patient with non-stabilized psycho-behavioral disorders (hallucinations, psychoses, impulse control disorders) dating from less than 6 months,
  • Patient with major cognitive impairment (Montreal Cognitive Assessment ≤24),

Other

  • Patient with acute depression not stabilized by treatment or dating from less than 6 months,
  • Patient who has already participated in a structured mindfulness meditation program
  • Patient placed under judicial safeguard, guardianship or curator ship,
  • Pregnant or breastfeeding women.

Who the study is looking for

  • Patient suffering from Parkinson's disease,
  • Patient aged over 18 and under 80,
  • Patient with a Hoehn and Yahr Stage of 1 to 3,
  • Patient affiliated or beneficiary of the social security system,
  • Patient having signed a free, informed and written consent

Age in the registry: 18 years to 79 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Xavier Arnozan Hospital
Coordinator of this site? Confirm its status
PessacFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.